Bronchodilator reversibility testing in COPD

被引：1
|
作者：
Cotes, JE [1 ]
机构：
[1] Med Sch Newcastle Upon Tyne, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
来源：
THORAX | 2004年 / 59卷 / 02期
关键词：
D O I：
10.1136/thorax.2003.014712
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [31] Lung Volume Reversibility Testing Improves Diagnostic Yield of Bronchodilator Response in Asthma
    Rashidian, Ali
    Sazgar, Sasan
    Mejia, Janil
    Tyner, Tim
    Abejie, Belayneh
    Jain, Vipul
    Vempilly, Jose
    CHEST, 2015, 148 (04)
  • [32] Usefulness of Bronchodilator Reversibility Test Using the Forced Oscillation Technique in Bronchial Asthma, COPD, and Asthma-COPD Overlap
    Nakayasu, H.
    Akamatsu, T.
    Tamura, K.
    Masuda, T.
    Takahashi, S.
    Tanaka, Y.
    Watanabe, H.
    Kishimoto, Y.
    Oishi, K.
    Saigusa, M.
    Yamamoto, A.
    Morita, S.
    Asada, K.
    Shirai, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [33] Clinical Implications of Bronchodilator Testing: Diagnosing and Differentiating COPD and Asthma-COPD Overlap
    Annangi, Srinadh
    Coz-Yataco, Angel O.
    RESPIRATORY CARE, 2022, 67 (04) : 440 - 447
  • [34] Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related
    Reid, David W.
    Wen, Yudong
    Johns, David P.
    Williams, Trevor J.
    Ward, Chris
    Walters, E. Haydn
    RESPIROLOGY, 2008, 13 (06) : 799 - 809
  • [35] The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD
    Ben Saad, Helmi
    Prefaut, Christian
    Tabka, Zouhair
    Zbidi, Abdelkrim
    Hayot, Maurice
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2008, 21 (05) : 767 - 773
  • [36] Rapid access spirometry and reversibility testing for COPD patients in the community
    Corless, JA
    Mitchell, P
    Swarbrick, P
    Warburton, CJ
    THORAX, 1999, 54 : A44 - A44
  • [37] Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD
    Molimard, M
    Bourcereau, J
    Le Gros, V
    Bourdeix, I
    RESPIRATORY MEDICINE, 2005, 99 (06) : 695 - 702
  • [38] Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation
    Maniscalco, Mauro
    Ambrosino, Pasquale
    Fuschillo, Salvatore
    Stufano, Silvia
    Sanduzzi, Alessandro
    Matera, Maria Gabriella
    Cazzola, Mario
    RESPIRATORY MEDICINE, 2021, 182
  • [39] Bronchodilator Response in COPD
    Martin, Vanina
    Lamot, Sebastian
    Solis, Marco
    Villa, Josefina
    Itcovici, Nicolas
    Quadrelli, Silvia
    CHEST, 2013, 144 (04)
  • [40] Bronchodilator Therapy in COPD
    Kirsten, A. -M.
    Watz, H.
    Magnussen, H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (06) : 264 - 267
12345